BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25936887)

  • 21. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
    Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
    Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer.
    Sin TK; Wang F; Meng F; Wong SC; Cho WC; Siu PM; Chan LW; Yung BY
    Int J Mol Sci; 2016 Feb; 17(2):237. PubMed ID: 26891293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment.
    Othman N; Nagoor NH
    Biomed Res Int; 2014; 2014():318030. PubMed ID: 24999473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells.
    An IS; An S; Kwon KJ; Kim YJ; Bae S
    Oncol Rep; 2013 Feb; 29(2):523-8. PubMed ID: 23152132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs.
    Li J; Zhong X; Zhao Y; Shen J; Pilapong C; Xiao Z
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of microRNAs and their target genes in non-small-cell lung cancer.
    Lee HY; Han SS; Rhee H; Park JH; Lee JS; Oh YM; Choi SS; Shin SH; Kim WJ
    Mol Med Rep; 2015 Mar; 11(3):2034-40. PubMed ID: 25376560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
    Mascaux C; Feser WJ; Lewis MT; Barón AE; Coldren CD; Merrick DT; Kennedy TC; Eckelberger JI; Rozeboom LM; Franklin WA; Minna JD; Bunn PA; Miller YE; Keith RL; Hirsch FR
    Cancer Prev Res (Phila); 2013 Feb; 6(2):100-8. PubMed ID: 23268837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comprehensive Identification of MicroRNAs Regulated by Long Non-coding RNA MALAT1].
    Zhang H; Wang G; Yin R; Qiu M; Xu L
    Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):247-51. PubMed ID: 27215451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA and Lung Cancer.
    Del Vescovo V; Denti MA
    Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation.
    Liu ZY; Zhang GL; Wang MM; Xiong YN; Cui HQ
    Asian Pac J Cancer Prev; 2011; 12(11):2819-23. PubMed ID: 22393947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions.
    Yao R; Wang Y; Lemon WJ; Lubet RA; You M
    Oncogene; 2004 Oct; 23(46):7746-52. PubMed ID: 15361829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
    Crawford M; Brawner E; Batte K; Yu L; Hunter MG; Otterson GA; Nuovo G; Marsh CB; Nana-Sinkam SP
    Biochem Biophys Res Commun; 2008 Sep; 373(4):607-12. PubMed ID: 18602365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavonoid display ability to target microRNAs in cancer pathogenesis.
    Singh S; Raza W; Parveen S; Meena A; Luqman S
    Biochem Pharmacol; 2021 Jul; 189():114409. PubMed ID: 33428895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
    Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
    Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1.
    Cheng D; Xu Y; Sun C; He Z
    Mol Cell Biochem; 2016 Dec; 423(1-2):85-91. PubMed ID: 27686452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention?
    Mactier KE; Glaire MA; Basavaraju U; El-Omar EM; Hold GL
    Eur J Cancer Prev; 2014 Nov; 23(6):540-9. PubMed ID: 24608603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.